Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4237416 | Journal of Vascular and Interventional Radiology | 2015 | 6 Pages |
Abstract
Transcatheter computed tomography (CT) arterial portography-guided percutaneous liver tumor ablation has been proved to be feasible and accurate in treating liver metastases from colorectal origin that are obscure on ultrasound and unenhanced CT. However, distinguishing local recurrence from scars after ablation can still be difficult. This report describes nine patients with recurrences after ablation in whom transcatheter CT hepatic arteriography allowed differentiation of recurring and residual tumor tissue (incomplete ring enhancing lesion) from tumor-free nonenhancing scars. Using CT hepatic arteriography, it is possible to plan and guide percutaneous retreatment and confirm technical success without performing oversized repeat ablations or jeopardizing patients renal function.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Aukje A.J.M. MD, Hester J. MD, Bram B. MD, Michiel H. MD, Marleen C.A.M. MD, Petrousjka M. MD, PhD, Martijn R. MD, PhD,